Jan 31, 2023 08:00AM
Jan 13, 2023 05:26AM
Jan 12, 2023 05:16AM
Jan 11, 2023 04:49AM
Jan 10, 2023 11:11AM
Jan 10, 2023 03:48AM
Jan 9, 2023 11:22AM Acer Therapeutics (ACER) 30-day option implied volatility at 126
Jan 9, 2023 04:08AM
Jan 6, 2023 04:45AM
Jan 4, 2023 04:47AM
Jan 3, 2023 02:52AM
Dec 30, 2022 04:06AM
Dec 29, 2022 04:19AM
Dec 28, 2022 01:50PM Acer Therapeutics (ACER) call put ratio 4.2 calls to 1 put
Nov 14, 2022 05:08PM
Oct 3, 2022 08:33AM
Oct 3, 2022 08:30AM
Aug 15, 2022 04:00PM
Aug 12, 2022 08:33AM
Aug 12, 2022 08:30AM
Jul 28, 2022 08:30AM Acer Therapeutics and Relief Therapeutics Announce FDA Acceptance for Review of NDA Resubmission for ACER-001 for Treatment of UCDs
Jul 18, 2022 08:31AM
Jul 18, 2022 08:30AM
Jun 7, 2022 08:32AM
Jun 7, 2022 08:30AM
May 16, 2022 04:01PM
May 6, 2022 08:30AM
May 6, 2022 01:40AM Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Genetic Metabolic Dieticians International Conference
Apr 12, 2022 08:30AM
Apr 12, 2022 01:20AM
Mar 7, 2022 09:56AM
Mar 7, 2022 06:15AM
Mar 2, 2022 05:19PM
Mar 2, 2022 05:18PM
Jan 27, 2022 08:30AM Acer Therapeutics and Relief Therapeutics Announce Presentation of Four ACER-001 Posters at the Upcoming SIMD and GMDI Conferences
Nov 19, 2021 05:03PM
Nov 19, 2021 05:00PM
Oct 26, 2021 08:35AM
Oct 26, 2021 08:30AM
Oct 7, 2021 08:33AM
Oct 7, 2021 08:30AM
Oct 6, 2021 08:31AM Acer Therapeutics (ACER) and Relief Therapeutics Announce FDA Acceptance of NDA for ACER-001 to Treat Urea Cycle Disorders
Oct 6, 2021 08:30AM
Jan 28, 2020 06:16PM
Dec 5, 2019 12:50PM
Sep 11, 2019 08:00PM
May 31, 2019 08:30AM
May 14, 2019 04:01PM
Mar 7, 2019 04:01PM Acer Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
Dec 26, 2018 08:32AM

14,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All